Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
The SARS-CoV-2 coronavirus epidemic has led to an increase in the number of people with depression. Symptoms related to the mental sphere (mainly depression and anxiety) may be experienced by one third of the worldwide population. This entails the need for the effective and rapid treatment of depres...
Guardado en:
Autores principales: | Mateusz Kowalczyk, Edward Kowalczyk, Paweł Kwiatkowski, Łukasz Łopusiewicz, Monika Sienkiewicz, Monika Talarowska |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca4145ee1a4041a6a0c0ffd99daea105 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
por: Muhammad Siddique Kakar, et al.
Publicado: (2020) -
Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
por: F Kheirkhah, et al.
Publicado: (2010) -
Mental Health of PhD Students at Polish Universities—Before the COVID-19 Outbreak
por: Mateusz Kowalczyk, et al.
Publicado: (2021) -
<i>N</i>-Methyl-<span style="font-variant: small-caps">d</span>-aspartic Acid (NMDA) Receptor Is Involved in the Inhibitory Effect of Ketamine on Human Sperm Functions
por: Ying Chen, et al.
Publicado: (2021) -
Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
por: Vasilescu AN, et al.
Publicado: (2017)